跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MEBEVERINE GXP mebeverine hydrochloride 135 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
MEBEVERINE GXP mebeverine hydrochloride 135 mg tablet blister pack
Approved
STANDARD
MEBEVERINE GXP mebeverine hydrochloride 135 mg tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
85f478f28f07c181
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
85f478f28f07c181
Product Name
MEBEVERINE GXP mebeverine hydrochloride 135 mg tablet blister pack
Artg Id
288811
Artg Name
MEBEVERINE GXP mebeverine hydrochloride 135 mg tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2018-04-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
85f478f28f07c181
Type
Standard
Back to TGA Approvals